Lv71
5000 积分 2022-06-21 加入
The Risk and Reversibility of Osimertinib-related Cardiotoxicity in a Real-World Population
1个月前
已关闭
The Risk and Reversibility of Osimertinib-related Cardiotoxicity in a Real-World Population
1个月前
已关闭
Management of common adverse events related to first-line dacomitinib use in EGFR mutation-positive non-small-cell lung cancer: a pooled safety analysis
2个月前
已完结
Digital PCR-Based Detection of EGFR Mutations in Paired Plasma and CSF Samples of Lung Adenocarcinoma Patients with Central Nervous System Metastases
2个月前
已完结
Epidermal Growth Factor Receptor Mutation Detection in Cerebrospinal Fluid of Lung Adenocarcinoma Patients with Leptomeningeal Metastasis
2个月前
已完结
Acquired resistance to TKIs in solid tumours: learning from lung cancer
2个月前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC
2个月前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC
2个月前
已完结
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study
2个月前
已完结
Ivonescimab Plus Chemotherapy in Non-Small Cell Lung Cancer With EGFR Variant: A Randomized Clinical Trial
2个月前
已完结
皖公网安备34019202002308
